Examples of using Primary hyperparathyroidism in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Would indicate primary hyperparathyroidism.
Primary hyperparathyroidism generally requires inpatient care and surgery.
Parathyroid carcinoma and Primary Hyperparathyroidism.
Primary hyperparathyroidism(PHP) is a relatively common disease occurring in approximately 0.3% of population.
Elevated calcium and P.T.H. would indicate primary hyperparathyroidism.
Most dogs with primary hyperparathyroidism do not appear ill.
No strategies exist for prevention of primary hyperparathyroidism;
There is no known genetic cause for primary hyperparathyroidism, but its association with certain breeds suggests a possible hereditary basis in some cases.
If you are being treated for parathyroid cancer or primary hyperparathyroidism.
In patients with parathyroid carcinoma or primary hyperparathyroidism, the recommended starting dose of Mimpara for adults is 30 mg twice a day.
Secondary hyperparathyroidism, parathyroid carcinoma and primary hyperparathyroidism.
Primary hyperparathyroidism- PTH-secreting tumor of the parathyroid gland; in most cases only one gland has a tumor; malignant tumors of the parathyroid glands are uncommon.
A further three studies compared Mimpara with placebo in a total of 136 patients with primary hyperparathyroidism over up to a year.
Primary hyperparathyroidism refers to a condition in which a tumor in the parathyroid gland produces excessive levels of parathyroid hormone, leading to increased blood calcium levels hypercalcemia.
The results of the additional studies supported the use of Mimpara for hypercalcaemia in patients with primary hyperparathyroidism.
In patients with parathyroid carcinoma or primary hyperparathyroidism, the side effects are similar to those seen in patients with long-standing kidney disease- the most frequent side effects are nausea and vomiting.
Common: hypocalcaemia(see section 4.4), reduced testosterone levels(see section 4.4)Parathyroid Carcinoma and Primary Hyperparathyroidism.
Mimpara has also been studied in a study involving 46 patients with hypercalcaemia,including 29 with parathyroid carcinoma, and 17 with primary hyperparathyroidism who could not have their parathyroid glands removed or in whom surgery to remove the parathyroid glands was not effective.
Mimpara produced a decrease in blood calcium of more than 1 mg/dl in 62% of the cancer patients(18 out of 29) andin 88% of the patients with primary hyperparathyroidism 15 out of 17.
Serum ionized calcium determination is often normal in patients with chronic renal failure andhigh in patients with primary hyperparathyroidism or hypercalcemia that is associated with a malignancy.
A further three studies compared the effectiveness of Mimpara andplacebo in a total of 136 patients with primary hyperparathyroidism over up to a year.
Postoperative low levels of calcium in the blood(hypocalcemia) is relatively common after surgical removal of one ormore parathyroid glands for treatment of primary hyperparathyroidism, especially in patients with presurgical calcium concentrations greater than 14 mg/d.
Mimpara is used:• to treat secondary hyperparathyroidism in patients with kidney disease on dialysis.• to reduce high levels of calcium in the blood(hypercalcaemia) in patients with parathyroid cancer.• to reduce high levels of calcium in the blood(hypercalcaemia)in patients with primary hyperparathyroidism who still have high calcium levels after removal of the parathyroid gland or when removal of the gland is not possible.